dr-sahmed-el-modir
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Consultant_Oncologist_Headshot_GA_Dr-Ahmed-El-Modir.jpg

Dr Ahmed El-Modir

Dr Ahmed El-Modir
Ahmed
El-Modir
MBBCh, FRCP, FRCR, MRCPI Consultant Oncologist

Languages spoken

English

Expert in

Chemotherapy, radiotherapy and immunotherapy

 

Interested in

Prostate, lung and gynaecological

Overview

Centres

Birmingham
Birmingham

Little Aston Hall Drive, Sutton Coldfield, B74 3BF

52.60208, -1.87412
/uk/our-centres/birmingham
+44 (0) 121 353 3055
mediahawkNumber3664 mhMobile

Specialises in

Gynaecological cancer
Condition
Condition/Cancer
Condition/Cancer/Gynaecological cancer
Lung cancer
Condition
Condition/Cancer
Condition/Cancer/Lung cancer
Prostate cancer
Condition
Condition/Cancer
Condition/Cancer/Prostate cancer

Treatments

Chemotherapy
Service
Service/Cancer
Service/Cancer/Medical oncology
Service/Cancer/Medical oncology/Chemotherapy

Special clinical interest in prostate, lung and gynaecological.

Dr Ahmed El-Modir completed his training in oncology in the West Midlands and was appointed as a consultant oncologist at University Hospital Birmingham in 2003. He is an honorary senior lecturer with Birmingham University. He is also a visiting oncologist to the Heart of England NHS Foundation Trust and Sandwell and West Birmingham Hospitals NHS Trust.

Dr El-Modir specialises in the treatment of cancer with chemotherapy, radiotherapy and immunotherapy. He is the principal investigator for a number of national trials. He has a special interest in clinical audit.

Career positions

Current position(s)

  • Consultant oncologist

Education

Universities

  • University of Birmingham

Residencies

  • University Hospital Birmingham
  • Sandwell and West Birmingham Hospitals NHS Trust
  • Heart of England NHS Foundation Trust

 

Expertise and interests

Expertise

Interests

  • Chemotherapy 
  • Radiotherapy
  • Immunotherapy

Accomplishments

Publications

  • Dr El-Modir is a member of the Royal College of Radiologists clinical oncology audit sub-committee.